Morpho, Inc. carries a market capitalization of 3.14B, placing it among publicly traded companies globally. Its enterprise value stands at 5.86B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.14B |
| Enterprise Value | 5.86B |
Morpho, Inc. currently has 5.13M shares outstanding.
| Shares Outstanding | 5.13M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Morpho, Inc. trades at a trailing price-to-earnings ratio of 49.22. The price-to-sales ratio is 2.95, and the price-to-book ratio stands at 4.83.
| PE Ratio | 49.22 |
| PS Ratio | 2.95 |
| PB Ratio | 4.83 |
| P/TBV Ratio | 2.68 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Morpho, Inc. trades at an EV/EBITDA multiple of 43.60 and an EV/FCF ratio of 5,671.71. The EV/Sales ratio of 2.00 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 43.60 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.00 |
| EV / EBITDA | 43.60 |
| EV / EBIT | 43.60 |
| EV / FCF | 5,671.71 |
Morpho, Inc. maintains a current ratio of 6.18, meaning it holds 6.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 6.18 |
| Quick Ratio | 4.99 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | 104.14 |
Morpho, Inc. posts a return on equity of 10.31 and a return on invested capital of 3.37.
| Return on Equity (ROE) | 10.31 |
| Return on Assets (ROA) | 4.78 |
| Return on Invested Capital (ROIC) | 3.37 |
| Return on Capital Employed (ROCE) | 10.37 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 35.69 |
Over the trailing twelve months, Morpho, Inc. has paid 43.77M in income taxes, reflecting an effective tax rate of 19.94.
| Income Tax | 43.77M |
| Effective Tax Rate | 19.94 |
Morpho, Inc.'s stock has declined approximately -49.03604% over the past 52 weeks. The 50-day moving average sits at 641.90, while the 200-day moving average is 788.96.
| Beta (5Y) | N/A |
| 52-Week Price Change | -49.03604% |
| 50-Day Moving Average | 641.90 |
| 200-Day Moving Average | 788.96 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Morpho, Inc. generated 2.93B in revenue and converted that into 175.71M in net income, yielding earnings per share of 34.26. EBITDA reached 134.34M, while operating income came in at 134.34M.
| Revenue | 2.93B |
| Gross Profit | 1.81B |
| Operating Income | 134.34M |
| Pretax Income | 219.48M |
| Net Income | 175.71M |
| EBITDA | 134.34M |
| EBIT | 134.34M |
| Earnings Per Share (EPS) | 34.26 |
Total book value stands at 1.79B, with working capital of 2.90B providing operational flexibility.
| Cash & Cash Equivalents | 2.79B |
| Total Debt | N/A |
| Net Debt | -2.79B |
| Equity (Book Value) | 1.79B |
| Book Value Per Share | 349.29 |
| Working Capital | 2.90B |
Morpho, Inc. operates with a gross margin of 61.88, reflecting its pricing power and cost economics. The operating margin of 4.58 and net profit margin of 6.00 provide insight into operational efficiency.
| Gross Margin | 61.88 |
| Operating Margin | 4.58 |
| Pretax Margin | 7.49 |
| Profit Margin | 6.00 |
| EBITDA Margin | 4.58 |
Morpho, Inc.'s most recent stock split took place on April 27, 2015 with a 1:3 split ratio.
| Last Split Date | 4/27/2015 |
| Split Ratio | 1:3 |
Morpho, Inc. posts an Altman Z-Score of 10.32, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 10.32 |